Jones Thomas Llewelyn, Roberts Claire, Elliott Scott, Glaysher Sharon, Green Ben, Shute Janis K, Chauhan Anoop J
Department of Respiratory Medicine, Portsmouth Hospitals University NHS Trust, Portsmouth, United Kingdom.
School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth, United Kingdom.
Interact J Med Res. 2024 Oct 8;13:e44397. doi: 10.2196/44397.
COPD (chronic obstructive pulmonary disease) and bronchiectasis are common, and exacerbations contribute to their morbidity and mortality. Predictive factors for the frequency of future exacerbations include previous exacerbation frequency and airway colonization. Earlier treatment of exacerbations is likely to reduce severity.
This study tested the hypothesis that, in a population with bronchiectasis, COPD, or both who have frequent exacerbations and airway colonization, changes in symptom scores or physiological variables within 10 days prior to an exacerbation would allow the prediction of the event.
We performed a 6-month, longitudinal, observational, cohort study among 30 participants with bronchiectasis, COPD, or both; at least 2 exacerbations per year; and colonization with Pseudomonas aeruginosa or Haemophilus influenzae. Daily symptom and physiological data were collected, comprising pulse rate, blood pressure, oxygen saturation, peak flow rate, step count, weight, and temperature. Exacerbations (defined as the onset of new antibiotic use for respiratory symptoms) were collected, and predictive values for abnormal values in the 10 days prior to an exacerbation were calculated.
A total of 30 participants were recruited, collecting a total of 39,534 physiological and 25,334 symptom data points across 5358 participant-days; these included 78 exacerbations across 27 participants, with the remaining 3 participants not having exacerbations within the 6-month observation period. Peak flow rate, oxygen saturation, and weight were significantly different at the point of exacerbation (all P<.001), but no significant trends around exacerbation were noted and no clinically beneficial predictive value was found in the overall or individually adjusted model. Symptom scores tended to worsen for 10 days on either side of an exacerbation but were of insufficient magnitude for prediction, with area under the receiver operating characteristic curve values of ranging from 0.4 to 0.6.
Within this small cohort with bronchiectasis, COPD, or both and airway colonization, physiological and symptom variables did not show sufficient predictive value for exacerbations to be of clinical utility. The self-management education provided as standard of care may be superior to either of these approaches, but benefit in another or larger cohort cannot be excluded.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.2196/resprot.6636.
慢性阻塞性肺疾病(COPD)和支气管扩张症较为常见,病情加重会增加其发病率和死亡率。未来病情加重频率的预测因素包括既往加重频率和气道定植情况。早期治疗病情加重可能会降低严重程度。
本研究检验了以下假设:在患有支气管扩张症、COPD或两者兼具且病情频繁加重和气道定植的人群中,病情加重前10天内症状评分或生理变量的变化能够预测病情加重事件。
我们对30名患有支气管扩张症、COPD或两者兼具的参与者进行了为期6个月的纵向观察性队列研究;每年至少病情加重2次;且感染铜绿假单胞菌或流感嗜血杆菌。收集每日症状和生理数据,包括脉搏率、血压、血氧饱和度、峰值流速、步数、体重和体温。收集病情加重情况(定义为因呼吸道症状开始使用新抗生素),并计算病情加重前10天内异常值的预测值。
共招募了30名参与者,在5358个参与者日中总共收集了39534个生理数据点和25334个症状数据点;其中27名参与者出现了78次病情加重,其余3名参与者在6个月观察期内未出现病情加重。病情加重时峰值流速、血氧饱和度和体重有显著差异(均P<0.001),但未观察到病情加重前后的显著趋势,在总体或单独调整模型中均未发现具有临床意义的预测价值。症状评分在病情加重前后10天内往往会恶化,但程度不足以用于预测,受试者工作特征曲线下面积值在0.4至0.6之间。
在这个患有支气管扩张症、COPD或两者兼具且气道定植的小队列中,生理和症状变量对病情加重的预测价值不足,无法用于临床。作为标准治疗提供的自我管理教育可能优于上述任何一种方法,但不能排除在其他或更大队列中有益的可能性。
国际注册报告识别码(IRRID):RR2-10.2196/resprot.6636。